BioCentury | Oct 11, 2018
Distillery Therapeutics

Ophthalmic disease

...24, 2018 doi:10.1523/JNEUROSCI.0897-18.2018 CONTACT: Koji Shibasaki, Gunma University Graduate School of Medicine, Maebashi, Japan email: shibasaki@gunma-u.ac.jp Claire Quang Gunma University Monocyte...
BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: An unknown pathway

...Ueno, M. et al. Nat. Commun.; published online Mar. 10, 2015 doi:10.1038/ncomms7332 CONTACT: Masahiko Kurabayashi, Gunma University...
BioCentury | Apr 2, 2015
Targets & Mechanisms

Breathing through bone drugs

...the rest of the body. Kurabayashi is chief professor of medicine and biological science at Gunma University...
...Inc. (Tokyo:2802), Tokyo, Japan EffRx Pharmaceuticals S.A., Lausanne, Switzerland Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Gunma University...
Items per page:
1 - 3 of 3
BioCentury | Oct 11, 2018
Distillery Therapeutics

Ophthalmic disease

...24, 2018 doi:10.1523/JNEUROSCI.0897-18.2018 CONTACT: Koji Shibasaki, Gunma University Graduate School of Medicine, Maebashi, Japan email: shibasaki@gunma-u.ac.jp Claire Quang Gunma University Monocyte...
BioCentury | Apr 2, 2015
Distillery Therapeutics

Therapeutics: An unknown pathway

...Ueno, M. et al. Nat. Commun.; published online Mar. 10, 2015 doi:10.1038/ncomms7332 CONTACT: Masahiko Kurabayashi, Gunma University...
BioCentury | Apr 2, 2015
Targets & Mechanisms

Breathing through bone drugs

...the rest of the body. Kurabayashi is chief professor of medicine and biological science at Gunma University...
...Inc. (Tokyo:2802), Tokyo, Japan EffRx Pharmaceuticals S.A., Lausanne, Switzerland Eisai Co. Ltd. (Tokyo:4523), Tokyo, Japan Gunma University...
Items per page:
1 - 3 of 3